Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity

Human Immunology

Volumn 52, Issue 2, 1997, Pages 138-143

  Streilein, J Wayne ^a   Takeuchi, Masaharu ^a   Taylor, Andrew W ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; EYE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; AUTOIMMUNITY; CLONAL ANERGY; CLONAL DELETION; HUMANS; IMMUNE TOLERANCE; MICE; ORGAN SPECIFICITY; T-LYMPHOCYTES;

EID: 0030992947     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00288-1     Document Type: Article

References (29)

1. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603, 1953.
2. Burnet FM. The clonal selection theory of acquired immunity. Cambridge: Cambridge University Press, 1959.
3. Owen RD: Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400, 1945.
4. Medawar P. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58, 1948.
5. Head JR, Neaves WB, Billingham RE: Reconsideration of the lymphatic drainage of the rat testis. Transpl 35:91, 1983.
6. Wilbanks GA, Streilein JW: The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen. Evidence that the eye acts as an antigen depot. Reg Imm 2:390, 1989.
7. Ksander BR, Streilein JW. Regulation of the immune response within privileged sites. Chem Imm 58:117, 1994.
8. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Hagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991.
9. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke DC. A role for CD95 ligand in preventing graft rejection. Nature 377:630, 1995.
10. Griffin TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189, 1995.
11. Lau HT, Yu M, Fontana A, Stoeckert Jr CJ: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109, 1996.
12. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH: Molecular events in the induction of a nonresponsive state in interleukin-2 producing helper T lymphocyte clones. Proc Natl Acad Sci USA 84:5409, 1987.
13. Kaiser CJ, Ksander BR, Streilein JW: Inhibition of lymphocyte proliferation by aqueous humor. Reg Imm 2:42, 1989.
14. Taylor AW, Streilein JW, Cousins SW: Immunoregulation of ocular effector responses by soluble factors in aqueous humor. Reg Imm 6:143, 1994.
15. Taylor AW, Streilein JW: Aqueous humor induces effector T cells to mediate immunosuppression. Invest Ophthal Vis Sci 37:S1113, 1996.
16. Cousins SW, Trattler WB, Streilein JW: Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res 10:287, 1991.
17. Kaplan HJ, Streilein JW: Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J Immunol 118:809, 1977.
18. Niederkorn JY, Streilein JW, Shadduck JA: Deviant immune responses to allogeneic tumors injected intracamerally in mice. Invest Ophtal Vis Sci 20:355, 1980.
19. Niederkorn JY, Streilein JW: Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses. J Immunol 131:2670, 1983.
20. Niederkorn JY, Streilein JW: Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transpl 33:573, 1982.
21. Wilbanks GA, Streilein JW: Distinctive humoral responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2a-secreting B cells. Immuno 71:566, 1990.
22. Kosiewicz MM, Streilein JW: Is deviant immunity induced by intraocular injection of antigen dependent on Th2 cells? Invest Ophthal Vis Sci 37:S1135, 1996.
23. Mizuno K, Clark AF, Streilein JW: Ocular injection of retinal S antigen: Suppression of autoimmune uveitis. Invest Ophthal Vis Sci 30:772, 1989.
24. Hara Y, Caspi RR, Wiggert B, Chan C-C, Wilbanks GA, Streilein JW: Suppression of experimental autoimmune uveitis in mice by induction of Anterior Chamber Associated Immune Deviation with interphotoreceptor retinoid binding protein. J Immunol 148:1685, 1992.
25. Streilein JW, Niederkorn JY: Characterization of the suppressor cell(s) responsible for Anterior Chamber Associated Immune Deviation (ACAID) in BALB/c mice by P815 cells. J Immunol 134:1381, 1985.
26. Wilbanks GA, Streilein JW: Studies on the induction of Anterior Chamber Associated Immune Deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 146:2610, 1991.
27. Wilbanks GA, Mammolenti MM, Streilein JW: Studies on the induction of Anterior Chamber Associated Immune Deviation (ACAID). II. Eye-derived cells participate in generating blood borne signals that induce ACAID. J Immunol 146:3018, 1991.
28. Wilbanks GA, Mammolenti MM, Streilein JW: Studies on the induction of Anterior Chamber Associated Immune Deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur J Immunol 22:165, 1992.
29. Takeuchi M, Kosiewicz MM, Streilein JW: On the mechanisms by which TGFβ alters functional properties of antigen presenting cells and T cells. Invest Ophthal Vis Sci 37:S533, 1996.